Denmark's Novo Nordisk , the world's biggest maker of insulin, said on Monday it would double the size of its research and development centre in Beijing to 200 employees by 2015.
"The expansion will mainly be dedicated to a new diabetes research unit," Novo Nordisk said in a statement. The company did not give any financial details
Jens Birgersson becomes new Brenntag CEO
Oxea is returning to its old name and its roots.
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
